6. Boehringer Ingelheim Vetmedica – Top 10 animal health companies

A cow and dog touching noses

BoehringerBoehringer Ingelheim Vetmedica
2015 Revenue: $1.49 billion (€1.36 billion)
HQ: St. Joseph, MO

The closely held Germany-based Boehringer Ingelheim has a strong presence in livestock health but has been looking to branch out into larger markets. In 2015, the company went a long way towards fulfilling that goal, when it announced it will hand over its consumer health business to Sanofi ($SNY) in exchange for No. 4 animal health giant Merial. BI expects that the $12.5 billion asset swap will double its annual animal health sales to €3.8 billion ($4.2 billion). BI was already having a strong year: In 2015, Vetmedica’s sales jumped 10% year-over-year to €1.4 billion ($1.5 billion), as strong demand for its swine vaccine Ingelvac Circoflex pushed sales of that product up 4% to €281 million ($317.9 million). The Merial deal, which is expected to close in 2016, will boost Vetmedica’s profile in companion-animal health, adding such blockbusters as Heartgard and NexGard for controlling parasites in dogs.

Related Articles: 
Boehringer Ingelheim charts strong growth in livestock meds ahead of Merial union
Sanofi, Boehringer to create new animal health giant in $12.5B asset swap
Boehringer Ingelheim unloads vet plant in Iowa to contract manufacturer

6. Boehringer Ingelheim Vetmedica – Top 10 animal health companies

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…